Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of antiepileptic and anticonvulsant drugs. Its structural configuration allows for selective interaction with neurological targets, enhancing drug efficacy and reducing side effects. Commonly employed in the production of beta-amino acid-based therapeutics, it contributes to improved metabolic stability and bioavailability in active compounds. Also utilized in research for designing peptidomimetics and enzyme inhibitors due to its fluorinated aromatic moiety and stereochemical purity.